Publicado 6 números por año
ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X
Indexed in
Lipid Nanocarriers: Influence of Lipids on Product Development and Pharmacokinetics
SINOPSIS
Lipid nanocarriers are on the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery. Owing to their size-dependent properties, lipid nanoparticles offer the possibility for development of new therapeutics and an alternative system to other colloidal counterparts for drug administration. An important point to be considered in the selection of a lipid for the carrier system is its effect on the properties of the nanocarrier and also its intended use, as different types of lipids differ in their nature. Researchers around the globe have tapped the potential of solid lipid nanoparticles (SLNs) in developing formulation(s) that can be administered by various routes such as oral, ocular, parenteral, topical, and pulmonary. Since the start of this millennium, a new generation of lipid nanoparticles, namely nanostructured lipid carriers (NLCs), lipid drug conjugates (LDCs), and pharmacosomes, has evolved that have the potential to overcome the limitations of SLNs. The current review article presents broad considerations on the influence of various types of lipids on the diverse characteristics of nanocarriers, encompassing their physicochemical, formulation, pharmacokinetic, and cytotoxic aspects.
-
Xu Wenting, Lim Soo-Jeong, Lee Mi-Kyung, Cellular uptake and antitumour activity of paclitaxel incorporated into trilaurin-based solid lipid nanoparticles in ovarian cancer, Journal of Microencapsulation, 30, 8, 2013. Crossref
-
Kiparissides Costas, Kammona Olga, Nanoscale carriers for targeted delivery of drugs and therapeutic biomolecules, The Canadian Journal of Chemical Engineering, 91, 4, 2013. Crossref
-
Pathak Kamla, Raghuvanshi Smita, Oral Bioavailability: Issues and Solutions via Nanoformulations, Clinical Pharmacokinetics, 54, 4, 2015. Crossref
-
Merhautova Jana, Demlova Regina, Slaby Ondrej, MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers, Frontiers in Pharmacology, 7, 2016. Crossref
-
Deshpande Ameya, Mohamed Majrad, Daftardar Saloni B., Patel Meghavi, Boddu Sai H.S., Nesamony Jerry, Solid Lipid Nanoparticles in Drug Delivery, in Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices, 2017. Crossref
-
Beloqui Ana, del Pozo-Rodríguez Ana, Isla Arantxazu, Rodríguez-Gascón Alicia, Solinís María Ángeles, Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs, Journal of Drug Delivery Science and Technology, 42, 2017. Crossref
-
Silva Jessica, Mendes Maria, Cova Tânia, Sousa João, Pais Alberto, Vitorino Carla, Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles, AAPS PharmSciTech, 19, 5, 2018. Crossref
-
Rouco Helena, Diaz-Rodriguez Patricia, Rama-Molinos Santiago, Remuñán-López Carmen, Landin Mariana, Delimiting the knowledge space and the design space of nanostructured lipid carriers through Artificial Intelligence tools, International Journal of Pharmaceutics, 553, 1-2, 2018. Crossref
-
Kapoor Bhupinder, Gupta Reena, Singh Sachin Kumar, Gulati Monica, Singh Saranjit, Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes, Advances in Colloid and Interface Science, 253, 2018. Crossref
-
Jin Shi-Jia, Jin Ming-Zhu, Xia Bai-Rong, Jin Wei-Lin, Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers, Frontiers in Oncology, 9, 2019. Crossref
-
Beraldo-de-Araújo Viviane Lucia, Beraldo-de-Araújo Anderson, Costa Juliana Souza Ribeiro, Pelegrine Ana Carolina Martins, Ribeiro Lígia Nunes Moraes, Paula Eneida de, Oliveira-Nascimento Laura, Excipient-excipient interactions in the development of nanocarriers: an innovative statistical approach for formulation decisions, Scientific Reports, 9, 1, 2019. Crossref
-
Routray Sudhansu Bhusan, Patra Ch. Niranjan, Raju Rajarani, Panigrahi Kahnu Charan, Jena Goutam Kumar, Lyophilized SLN of Cinnacalcet HCl: BBD enabled optimization, characterization and pharmacokinetic study, Drug Development and Industrial Pharmacy, 46, 7, 2020. Crossref
-
Al‐Husaini Khalsa, Elkamel Erij, Han Xiaoxia, Chen Pu, Therapeutic potential of a cell penetrating peptide (CPP, NP1) mediated siRNA delivery: Evidence in 3D spheroids of colon cancer cells, The Canadian Journal of Chemical Engineering, 98, 6, 2020. Crossref
-
Harwansh Ranjit K., Bahadur Shiv, Deshmukh Rohitas, Rahman Md. A., Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective, Current Pharmaceutical Design, 26, 11, 2020. Crossref
-
Rouco Helena, Diaz-Rodriguez Patricia, Remuñán-López Carmen, Landin Mariana, Recent advances in solid lipid nanoparticles formulation and clinical applications, in Nanomaterials for Clinical Applications, 2020. Crossref
-
Wang Yi, Lai Wing-Fu, Systemic Delivery in Anti-aging Medicine: An Overview, in Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications, 13, 2020. Crossref
-
Rouco Helena, Diaz-Rodriguez Patricia, Gaspar Diana P., Gonçalves Lídia M. D., Cuerva Miguel, Remuñán-López Carmen, Almeida António J., Landin Mariana, Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn’s Disease, Nanomaterials, 10, 11, 2020. Crossref
-
Xue Fangqin, Lin Xiao, Cai Zhixiong, Liu Xiaolong, Ma Yuan, Wu Ming, Doxifluridine-based pharmacosomes delivering miR-122 as tumor microenvironments-activated nanoplatforms for synergistic treatment of hepatocellular carcinoma, Colloids and Surfaces B: Biointerfaces, 197, 2021. Crossref
-
Gandhi Gayatri, Abdullah Syahril, Foead Agus Iwan, Yeo Wendy Wai Yeng, The potential role of miRNA therapies in spinal muscle atrophy, Journal of the Neurological Sciences, 427, 2021. Crossref
-
Slaby Ondrej, Laga Richard, Sedlacek Ondrej, Therapeutic targeting of non-coding RNAs in cancer, Biochemical Journal, 474, 24, 2017. Crossref
-
Kyriakoudi Anastasia, Spanidi Eleni, Mourtzinos Ioannis, Gardikis Konstantinos, Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications, Plants, 10, 6, 2021. Crossref
-
Limongi Tania, Susa Francesca, Marini Monica, Allione Marco, Torre Bruno, Pisano Roberto, di Fabrizio Enzo, Lipid-Based Nanovesicular Drug Delivery Systems, Nanomaterials, 11, 12, 2021. Crossref
-
Kumbhar Popat, Shinde Tejaswini, Jadhav Tejaswini, Gavade Tejas, Sorate Rushikesh, Mali Uma, Disouza John, Manjappa Arehalli, Pharmacosomes: An approach to improve biopharmaceutical properties of drugs basic considerations in development, Research Journal of Pharmacy and Technology, 2021. Crossref
-
PRIYANKA PALLERLA, SRI REKHA M., DEVI A. SEETHA, REVIEW ON FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES FOR VAGINAL APPLICATION, International Journal of Pharmacy and Pharmaceutical Sciences, 2022. Crossref
-
Almeida Furquim de Camargo Bruna, Fonseca-Santos Bruno, Gonçalves Carvalho Suzana, Corrêa Carvalho Gabriela, Delello Di Filippo Leonardo, Sousa Araújo Victor Hugo, Lobato Duarte Jonatas, Polli Silvestre Amanda Letícia, Bauab Taís Maria, Chorilli Marlus, Functionalized lipid-based drug delivery nanosystems for the treatment of human infectious diseases, Critical Reviews in Microbiology, 2022. Crossref
-
Sargazi Saman, Arshad Rabia, Ghamari Reza, Rahdar Abbas, Bakhshi Ali, Karkan Sonia Fathi, Ajalli Narges, Bilal Muhammad, Díez‐Pascual Ana M., siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review, Cell Biology International, 46, 9, 2022. Crossref
-
Ehsan Sumia, Covarrubias-Zambrano Obdulia, Bossmann Stefan H., Mitochondrial Targeting Peptide-based Nanodelivery for Cancer Treatment, Current Protein & Peptide Science, 23, 10, 2022. Crossref
-
Shinde R. R., Chaudhari B. P., Velhal A. B., Redasani V. K., Pharmacosome as a Vesicular Drug Delivery System, Asian Journal of Research in Pharmaceutical Sciences, 2022. Crossref